enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. AstraZeneca's Dapagliflozin No Longer Authorized For Type 1 ...

   www.aol.com/news/astrazenecas-dapagliflozin-no...

   AstraZeneca Plc's (NASDAQ: AZN) dapagliflozin 5mg (Forxiga/Farxiga) was authorized in 2019 as an adjunct to insulin in patients with type 1 diabetes with a body-mass index (BMI) of 27 kg per m2. ...

3. Dapagliflozin - Wikipedia

   en.wikipedia.org/wiki/Dapagliflozin

   Dapagliflozin is used along with diet, exercise, and usually with other glucose-lowering medications, to improve glycaemic control in adults with type 2 diabetes. . Dapagliflozin, in addition to other SGLT2-inhibitors, was shown to reduce the rate of decline in kidney function and kidney failure in non-diabetic and type 2 diabetic adults when added to the existing treatment

4. SGLT2 inhibitor - Wikipedia

   en.wikipedia.org/wiki/SGLT2_inhibitor

   Dapagliflozin disposition is not evidently affected by body mass index (BMI) or body weight, therefore the pharmacokinetic findings are expected to be applicable to patients with a higher BMI. Dapagliflozin resulted in dose-dependent increases excretions in urinary glucose, up to 47g/d following single-dose administration, which can be expected ...

5. Dapagliflozin/saxagliptin - Wikipedia

   en.wikipedia.org/wiki/Dapagliflozin/saxagliptin

   In the European Union, it is indicated in adults aged 18 years and older with type 2 diabetes: to improve glycemic control when metformin with or without sulphonylurea (SU) and either saxagliptin or dapagliflozin does not provide adequate glycemic control. [3] when already being treated with saxagliptin and dapagliflozin. [3]

6. In weight loss battle, Novo and Lilly face growing offensive ...

   www.aol.com/news/weight-loss-battle-novo-lilly...

   As Novo Nordisk and Eli Lilly expand sales of their popular diabetes and weight-loss drugs, cheaper copies of their patented remedies are winning approval from some regulators overseas, posing a ...

7. Dapagliflozin/metformin - Wikipedia

   en.wikipedia.org/wiki/Dapagliflozin/metformin

   Canagliflozin, dapagliflozin, and empagliflozin should each be stopped at least three days before, and ertugliflozin should be stopped at least four days before scheduled surgery. [ 8 ] Symptoms of ketoacidosis include nausea, vomiting, abdominal pain, tiredness, and trouble breathing.